Creative Financial Designs Inc Biogen Inc. Transaction History

Creative Financial Designs Inc

$1.16 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	SELL	$275.25 - $318.06 $6,055 - $6,997	-22 Reduced 64.71%	12 $3,000
Q1 2023 Apr 25, 2023	SELL	$256.56 - $292.34 $256 - $292	-1 Reduced 2.86%	34 $9,000
Q4 2022 Feb 01, 2023	BUY	$252.44 - $306.72 $1,262 - $1,533	5 Added 16.67%	35 $9,000
Q2 2022 Aug 01, 2022	SELL	$187.54 - $223.02 $28,506 - $33,899	-152 Reduced 83.52%	30 $6,000
Q1 2022 Apr 15, 2022	SELL	$193.77 - $244.14 $1.92 Million - $2.42 Million	-9,894 Reduced 98.19%	182 $38,000
Q4 2021 Jan 26, 2022	BUY	$223.92 - $287.77 $374,170 - $480,863	1,671 Added 19.88%	10,076 $2.42 Million
Q3 2021 Oct 08, 2021	BUY	$282.99 - $369.05 $243,937 - $318,121	862 Added 11.43%	8,405 $2.38 Million
Q2 2021 Jul 27, 2021	BUY	$259.0 - $414.71 $274,799 - $440,007	1,061 Added 16.37%	7,543 $2.61 Million
Q1 2021 Apr 19, 2021	BUY	$242.95 - $284.63 $382,160 - $447,722	1,573 Added 32.04%	6,482 $1.81 Million
Q4 2020 Jan 08, 2021	BUY	$236.26 - $355.63 $292,489 - $440,269	1,238 Added 33.72%	4,909 $1.2 Million
Q3 2020 Oct 06, 2020	BUY	$264.77 - $305.71 $903,130 - $1.04 Million	3,411 Added 1311.92%	3,671 $1.04 Million
Q2 2020 Jul 23, 2020	BUY	$258.66 - $342.55 $67,251 - $89,063	260 New	260 $70,000
Q1 2019 Apr 23, 2019	SELL	$216.71 - $338.96 $1,300 - $2,033	-6 Closed	0 $0
Q4 2018 Jan 24, 2019	SELL	$278.5 - $352.75 $835 - $1,058	-3 Reduced 33.33%	6 $2,000
Q3 2018 Nov 02, 2018	SELL	$293.51 - $383.83 $15,556 - $20,342	-53 Reduced 85.48%	9 $3,000
Q2 2018 Jul 13, 2018	BUY	$257.52 - $306.91 $9,528 - $11,355	37 Added 148.0%	62 $18,000
Q4 2017 May 02, 2018	BUY	$307.64 - $344.58 $7,691 - $8,614	25	25 $8,000

Others Institutions Holding BIIB

# of Institutions

1,032

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

News

Stay updated on Creative Financial Designs Inc with notifications on news.

Account